Similar articles for PMID: 9846068

Year	Number of Results
1993	2
1994	4
1996	3
1997	2
1998	6
1999	3
2002	2
2004	1
2005	1
2006	6
2007	2
2008	1
2009	3
2010	5
2011	1
2012	2
2013	1
2015	2
2016	1
2018	1
2024	0

1

The effects of various excipients on the unfolding of basic fibroblast growth factor.

Shah D, Johnston TP, Heitz S, Mitra AK. Shah D, et al. PDA J Pharm Sci Technol. 1998 Sep-Oct;52(5):209-14. PDA J Pharm Sci Technol. 1998. PMID: 9846068

2

Permeation of unfolded basic fibroblast growth factor (bFGF) across rabbit buccal mucosa--does unfolding of bFGF enhance transport?

Johnston TP, Rahman A, Alur H, Shah D, Mitra AK. Johnston TP, et al. Pharm Res. 1998 Feb;15(2):246-53. doi: 10.1023/a:1011966602179. Pharm Res. 1998. PMID: 9523311

3

The stability of bFGF against thermal denaturation.

Vemuri S, Beylin I, Sluzky V, Stratton P, Eberlein G, Wang YJ. Vemuri S, et al. J Pharm Pharmacol. 1994 Jun;46(6):481-6. doi: 10.1111/j.2042-7158.1994.tb03831.x. J Pharm Pharmacol. 1994. PMID: 7932043

4

Reversible thermal denaturation of human FGF-1 induced by low concentrations of guanidine hydrochloride.

Blaber SI, Culajay JF, Khurana A, Blaber M. Blaber SI, et al. Biophys J. 1999 Jul;77(1):470-7. doi: 10.1016/S0006-3495(99)76904-3. Biophys J. 1999. PMID: 10388772 Free PMC article.

5

Effects of cyclodextrins on chemically and thermally induced unfolding and aggregation of lysozyme and basic fibroblast growth factor.

Tavornvipas S, Hirayama F, Takeda S, Arima H, Uekama K. Tavornvipas S, et al. J Pharm Sci. 2006 Dec;95(12):2722-9. doi: 10.1002/jps.20715. J Pharm Sci. 2006. PMID: 16917853

6

Chromatographic methods for quantitative analysis of native, denatured, and aggregated basic fibroblast growth factor in solution formulations.

Sluzky V, Shahrokh Z, Stratton P, Eberlein G, Wang YJ. Sluzky V, et al. Pharm Res. 1994 Apr;11(4):485-90. doi: 10.1023/a:1018946011652. Pharm Res. 1994. PMID: 8058602

7

Probing the conformation of protein (bFGF) precipitates by fluorescence spectroscopy.

Shahrokh Z, Eberlein G, Wang YJ. Shahrokh Z, et al. J Pharm Biomed Anal. 1994 Aug;12(8):1035-41. doi: 10.1016/0731-7085(94)e0030-5. J Pharm Biomed Anal. 1994. PMID: 7819377

8

Complexation of basic fibroblast growth factor with gelatin.

Muniruzzaman, Tabata Y, Ikada Y. Muniruzzaman, et al. J Biomater Sci Polym Ed. 1998;9(5):459-73. doi: 10.1163/156856298x00569. J Biomater Sci Polym Ed. 1998. PMID: 9648027

9

Development of inhalable dry powder formulation of basic fibroblast growth factor.

Ibrahim BM, Jun SW, Lee MY, Kang SH, Yeo Y. Ibrahim BM, et al. Int J Pharm. 2010 Jan 29;385(1-2):66-72. doi: 10.1016/j.ijpharm.2009.10.029. Epub 2009 Oct 21. Int J Pharm. 2010. PMID: 19853028

10

Nature of Interaction between basic fibroblast growth factor and the antiangiogenic drug 7,7-(carbonyl-bis[imino-N-methyl-4,2-pyrrolecarbonylimino[N-methyl-4,2-pyrrole]-carbonylimino])-bis-(1,3-naphtalene disulfonate). II. Removal of polar interactions affects protein folding.

Zamai M, Hariharan C, Pines D, Safran M, Yayon A, Caiolfa VR, Cohen-Luria R, Pines E, Parola AH. Zamai M, et al. Biophys J. 2002 May;82(5):2652-64. doi: 10.1016/S0006-3495(02)75607-5. Biophys J. 2002. PMID: 11964252 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

44 results

Results by year